Successful management of a patient with triple infection (MDR-TB/HIV/HCV) using new WHO recommendations

A. Skrahin (Minsk, Belarus)

Source: Virtual Congress 2020 – Respiratory infections
Session: Respiratory infections
Session type: Challenging clinical cases
Number: 3965
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahin (Minsk, Belarus). Successful management of a patient with triple infection (MDR-TB/HIV/HCV) using new WHO recommendations. Virtual Congress 2020 – Respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018

Clinical management: recommended practice including the place of antibiotics
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007

A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014

Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011

Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008

The standardised treatment of pulmonary TB: outcomes, problems and suggestions
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005

ERS short guidelines on COVID-19 management
Source: ERS webinar 2021: ERS short guidelines on COVID-19 management
Year: 2021

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
Source: Eur Respir J 2015; 45: 1170-1173
Year: 2015

Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011

Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy
Source: Eur Respir J 2005; 26: Suppl. 49, 192s
Year: 2005

Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010

Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Year: 2021

Challenges in the prevention, diagnosis, and treatment of tuberculosis in children
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019

COPD self management: The impact of implementing self management plans & rescue medications across 3 hospitals
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012

How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A
Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years
Year: 2021